MX384122B - Composición para uso para mejorar la consistencia o la frecuencia de las heces en infantes o niños pequeños. - Google Patents

Composición para uso para mejorar la consistencia o la frecuencia de las heces en infantes o niños pequeños.

Info

Publication number
MX384122B
MX384122B MX2017011007A MX2017011007A MX384122B MX 384122 B MX384122 B MX 384122B MX 2017011007 A MX2017011007 A MX 2017011007A MX 2017011007 A MX2017011007 A MX 2017011007A MX 384122 B MX384122 B MX 384122B
Authority
MX
Mexico
Prior art keywords
frequency
consistency
stools
infants
composition
Prior art date
Application number
MX2017011007A
Other languages
English (en)
Other versions
MX2017011007A (es
Inventor
Delphine Egli
Dominique Brassart
Norbert Sprenger
Original Assignee
Soc Des Produits Nestle S A Star
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=52726945&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX384122(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Soc Des Produits Nestle S A Star filed Critical Soc Des Produits Nestle S A Star
Publication of MX2017011007A publication Critical patent/MX2017011007A/es
Publication of MX384122B publication Critical patent/MX384122B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/125—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
    • A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/11—Lactobacillus
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/21—Streptococcus, lactococcus
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/51—Bifidobacterium
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K2035/11—Medicinal preparations comprising living procariotic cells
    • A61K2035/115—Probiotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • Engineering & Computer Science (AREA)
  • Nutrition Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Pediatric Medicine (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Physiology (AREA)
  • Zoology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

La presente invención se refiere a una composición nutritiva sintética en la fabricación de un medicamento para prevenir y/o tratar el estreñimiento y/o reducir la dureza de las heces y/o aumentar la frecuencia y/o prevenir y/o tratar la flatulencia, la hinchazón, los cólicos y/o el malestar intestinal en un infante o un niño pequeño, en donde la composición nutritiva sintética comprende al menos un oligosacárido fucosilado seleccionado de 2´-fucosillactosa (2´FL) y al menos un microorganismos probiótico, en donde la composición nutritiva comprende el (los) oligosacárido(s) fucosilados(s) en una cantidad total de 0.8-1.5 g/L de la composición y/o en una cantidad total de 0.55-1.05 g/100 g de composición sobre una base de peso seco, en donde la composición nutritiva comprende el microorganismo probíotico en una cantidad de 103 a 1012 ufc/g de dicha composición (pesos seco) y en donde el infante es un niño menor de 12 meses y el niño pequeño es un niño de entre un año y tres años.
MX2017011007A 2015-03-05 2016-03-04 Composición para uso para mejorar la consistencia o la frecuencia de las heces en infantes o niños pequeños. MX384122B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP15157724 2015-03-05
PCT/EP2016/054613 WO2016139329A1 (en) 2015-03-05 2016-03-04 Compositions for use in improving stool consistency or frequency in infants or young children

Publications (2)

Publication Number Publication Date
MX2017011007A MX2017011007A (es) 2017-10-20
MX384122B true MX384122B (es) 2025-03-14

Family

ID=52726945

Family Applications (2)

Application Number Title Priority Date Filing Date
MX2017010923A MX2017010923A (es) 2015-03-05 2016-03-04 Composiciones para usar en el mejoramiento de la consistencia o la frecuencia de las heces en infantes o niños pequeños.
MX2017011007A MX384122B (es) 2015-03-05 2016-03-04 Composición para uso para mejorar la consistencia o la frecuencia de las heces en infantes o niños pequeños.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
MX2017010923A MX2017010923A (es) 2015-03-05 2016-03-04 Composiciones para usar en el mejoramiento de la consistencia o la frecuencia de las heces en infantes o niños pequeños.

Country Status (11)

Country Link
US (4) US10821124B2 (es)
EP (4) EP4508990A3 (es)
CN (4) CN107846957A (es)
AU (2) AU2016227597B2 (es)
ES (2) ES3004085T3 (es)
FI (1) FI3264922T3 (es)
MX (2) MX2017010923A (es)
PH (2) PH12017550041B1 (es)
PT (1) PT3264922T (es)
RU (2) RU2731154C2 (es)
WO (2) WO2016139330A1 (es)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY182925A (en) 2014-10-31 2021-02-05 Nestle Sa Composition comprising fut2-dependent oligosaccharides and lacto-n-neotetraose for use in promoting brain development and cognition
PT3264922T (pt) * 2015-03-05 2025-01-07 Nestle Sa Composições para utilização na melhoria da consistência ou frequência das fezes em lactentes ou crianças pequenas
EP3331534B1 (en) * 2015-08-04 2019-12-18 Société des Produits Nestlé S.A. Nutritional compositions with 2fl and lnnt for use in inducing a gut microbiota close to the one of breast fed infants
AU2018272764B2 (en) 2017-05-24 2024-05-30 Societe Des Produits Nestle S.A. HMOs blends for use in infants or young children for health purposes
MX2020007197A (es) 2017-12-22 2020-09-03 Nestle Sa Composiciones para usar en la reduccion de la nocicepcion en infantes y niños pequeños.
EP3737384B1 (en) * 2018-03-08 2023-10-25 Purepharm Inc. Methods and compositions for preventing and treating conditions related to alpha-synuclein
CN110839702A (zh) * 2018-08-21 2020-02-28 内蒙古伊利实业集团股份有限公司 一种改善婴幼儿肠道菌群丰度和粪便气味的母乳低聚糖组合物及其应用
ES3028208T3 (en) 2018-12-21 2025-06-18 Nestle Sa A nutritional composition comprising a combination of human milk oligosaccharides to improve the gastrointestinal barrier
PL3979827T3 (pl) * 2019-06-04 2024-01-15 N.V. Nutricia Kompozycja żywieniowa zawierająca 2'fukozylolaktozę i 3'galaktozylolaktozę
BR112022008956A2 (pt) 2019-12-06 2022-08-02 Nestle Sa Composições para uso na redução de dor e/ou percepção de dor em bebês e crianças pequenas
CN114786501A (zh) * 2019-12-11 2022-07-22 雀巢产品有限公司 用于减少婴儿和幼儿的伤害感觉和/或其他健康益处的组合物
JP7790874B2 (ja) * 2021-03-31 2025-12-23 株式会社明治 乳幼児用排便促進剤
US11712445B2 (en) * 2021-04-30 2023-08-01 Sourabh Kharait Compositions and methods for improving gastrointestinal function in subjects with renal disease
CN120167627A (zh) * 2025-05-21 2025-06-20 美维仕(北京)健康管理有限公司 改善认知的包含益生菌与低聚糖的营养组合物及其用途

Family Cites Families (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991016449A1 (en) 1990-04-16 1991-10-31 The Trustees Of The University Of Pennsylvania Saccharide compositions, methods and apparatus for their synthesis
US5545553A (en) 1994-09-26 1996-08-13 The Rockefeller University Glycosyltransferases for biosynthesis of oligosaccharides, and genes encoding them
US20020019991A1 (en) 1998-04-30 2002-02-14 Abbott Laboratories Compositions containing an alpha 1,2-fucose linkage and uses thereof
EP2272522B1 (en) 2002-06-28 2017-09-06 Nestec S.A. Therapeutic compositions for use in prophylaxis or treatment of diarrheas
GB0308104D0 (en) 2003-04-08 2003-05-14 Novartis Nutrition Ag Organic compounds
WO2005055944A2 (en) 2003-12-05 2005-06-23 Cincinnati Children's Hospital Medical Center Oligosaccharide compositions and use thereof in the treatment of infection
BRPI0708701A2 (pt) * 2006-03-10 2011-06-07 Nutricia Nv uso de um sacarìdeo não digerìvel solúvel em água
ES2668552T3 (es) 2007-03-21 2018-05-18 Nestec S.A. Sistema de seguridad para composiciones nutricionales en polvo
WO2008115046A1 (en) * 2007-03-22 2008-09-25 N.V. Nutricia Cereal-based infant nutrition with fibre
WO2008153377A1 (en) 2007-06-15 2008-12-18 N.V. Nutricia Nutrition with non-viable bifidobacterium and non-digestible oligosaccharide
EP2072052A1 (en) * 2007-12-17 2009-06-24 Nestec S.A. Prevention of opportunistic infections in immune-compromised subjects
EP2459202A1 (en) * 2009-07-31 2012-06-06 Nestec S.A. Nutritional composition for breast-fed infants or pets with probiotics and selected nutrients
WO2011136648A1 (en) 2010-04-27 2011-11-03 N.V. Nutricia Use of human milk oligosaccharides in infant nutrition
EP2465509A1 (en) * 2010-11-23 2012-06-20 Nestec S.A. Oligosaccharide composition for treating acute respiratory tract infections
EP2454948A1 (en) * 2010-11-23 2012-05-23 Nestec S.A. Oligosaccharide mixture and food product comprising this mixture, especially infant formula
EP2455387A1 (en) 2010-11-23 2012-05-23 Nestec S.A. Oligosaccharide mixture and food product comprising this mixture, especially infant formula
EP2465507A1 (en) * 2010-11-23 2012-06-20 Nestec S.A. Oligosaccharide composition for treating skin diseases
NZ611807A (en) * 2010-12-31 2015-02-27 Abbott Lab Methods for decreasing the incidence of necrotizing enterocolitis in infants, toddlers, or children using human milk oligosaccharides
BR112013016929A2 (pt) * 2010-12-31 2019-09-24 Abbott Lab oligossacarídeos de leite humano para promover o crescimento de bactérias benéficas
AU2012215042B2 (en) * 2011-02-10 2016-01-14 Société des Produits Nestlé S.A. Modulation of growth of bifidobacteria using a combination of oligosaccharides found in human milk
JP6129821B2 (ja) * 2011-05-13 2017-05-17 グリコシン リミテッド ライアビリティー カンパニー プレバイオティクスとしての、精製された２’−フコシルラクトース、３−フコシルラクトース、およびラクトジフコテトラオースの使用
EP2522232A1 (en) * 2011-05-13 2012-11-14 Nestec S.A. Nutritional products comprising human milk oligosaccharides and methods for manufacture thereof
US10639319B2 (en) 2011-08-29 2020-05-05 Abbott Laboratories Human milk oligosaccharides for preventing injury and/or promoting healing of the gastrointestinal tract
EP2842560A4 (en) * 2012-04-23 2015-12-02 Univ Kyoto COMPOSITION TO PROMOTE THE GROWTH OF BIFIDOBAKTERIA
WO2013187755A1 (en) 2012-06-14 2013-12-19 N.V. Nutricia Fermented infant formula with non digestible oligosaccharides
WO2015071131A1 (en) * 2013-11-15 2015-05-21 Nestec S.A. Compositions for preventing or treating allergies in infants from or fed by non secretor mothers by providing fucosylated-oligosaccharides in particular among infants at risk or born by c-section
RU2016123464A (ru) 2013-11-15 2017-12-20 Нестек С.А. Композиции для применения в целях профилактики или лечения некротизирующего энтероколита у детей грудного или младшего возраста, рожденных с помощью кесарева сечения
ES2856013T3 (es) * 2013-11-15 2021-09-27 Nestle Sa Composiciones para su uso en la prevención o tratamiento de infecciones del TRS en bebés o niños jóvenes en riesgo
AU2015323762A1 (en) * 2014-09-25 2017-02-16 Société des Produits Nestlé S.A. Infant formula system with adaptive levels of human milk oligosaccharides (HMOs)
CN107249611A (zh) * 2014-10-24 2017-10-13 进化生物系统股份有限公司 活化的双歧杆菌及其应用方法
US20160346303A1 (en) * 2014-10-29 2016-12-01 Glycom A/S Synthetic composition and method for treating irritable bowel syndrome
MY182925A (en) * 2014-10-31 2021-02-05 Nestle Sa Composition comprising fut2-dependent oligosaccharides and lacto-n-neotetraose for use in promoting brain development and cognition
WO2016086151A1 (en) 2014-11-26 2016-06-02 Abbott Laboratories Infant formula with rrr-alpha-tocopherol, 2'-fucosyllactose, and a probiotic
MX380540B (es) * 2015-03-05 2025-03-12 Soc Des Produits Nestle S A Star Composiciones para uso en la prevención o el tratamiento de otitis o bronquitis en infantes o niños pequeños.
MX378680B (es) * 2015-03-05 2025-03-11 Soc Des Produits Nestle S A Star Composiciones para usar en la prevencion o el tratamiento de infecciones/inflamaciones gastrointestinales en infantes o niños pequeños.
PT3264922T (pt) * 2015-03-05 2025-01-07 Nestle Sa Composições para utilização na melhoria da consistência ou frequência das fezes em lactentes ou crianças pequenas
EP3331534B1 (en) * 2015-08-04 2019-12-18 Société des Produits Nestlé S.A. Nutritional compositions with 2fl and lnnt for use in inducing a gut microbiota close to the one of breast fed infants
MX382373B (es) * 2016-01-26 2025-03-13 Soc Des Produits Nestle S A Star Oligosacáridos de la leche humana para beneficios de la salud mediante la prevención del rebote adiposo precoz.
US20210205341A1 (en) * 2016-01-26 2021-07-08 Nestec S.A. Compositions comprising human milk oligosaccharides for use in infants or young children to prevent or treat a health disorder by increasing glp-1 secretion
WO2017129646A1 (en) * 2016-01-26 2017-08-03 Nestec S.A. Human milk oligosaccharides against later in life excessive fat mass accumulation and related health disorders
MX2018009016A (es) * 2016-01-26 2018-09-28 Nestec Sa Composiciones que comprenden oligosacaridos sialilados para usar en infantes o niños pequeños para prevenir la obesidad mas adelante en la vida o comorbilidades relacionadas y promover un crecimiento sano.
AU2018272764B2 (en) * 2017-05-24 2024-05-30 Societe Des Produits Nestle S.A. HMOs blends for use in infants or young children for health purposes
ES3028208T3 (en) * 2018-12-21 2025-06-18 Nestle Sa A nutritional composition comprising a combination of human milk oligosaccharides to improve the gastrointestinal barrier
CN114786501A (zh) * 2019-12-11 2022-07-22 雀巢产品有限公司 用于减少婴儿和幼儿的伤害感觉和/或其他健康益处的组合物

Also Published As

Publication number Publication date
RU2017133801A3 (es) 2019-09-17
US20180078573A1 (en) 2018-03-22
PH12017550039A1 (en) 2018-01-15
ES3000670T3 (en) 2025-03-03
EP3264921B1 (en) 2024-10-30
RU2017134672A (ru) 2019-04-05
EP4508990A3 (en) 2025-04-23
CN107404931A (zh) 2017-11-28
CN122030617A (zh) 2026-05-15
EP3264922A1 (en) 2018-01-10
AU2016227597A1 (en) 2017-07-27
AU2016227596B2 (en) 2020-01-16
EP3264922B1 (en) 2024-10-30
RU2017133801A (ru) 2019-04-05
AU2016227596A1 (en) 2017-07-27
WO2016139329A1 (en) 2016-09-09
MX2017011007A (es) 2017-10-20
CN122229194A (zh) 2026-06-19
ES3004085T3 (en) 2025-03-11
RU2731154C2 (ru) 2020-08-31
RU2017134672A3 (es) 2019-08-20
EP4494482A2 (en) 2025-01-22
US10821124B2 (en) 2020-11-03
US20210023102A1 (en) 2021-01-28
US20180078572A1 (en) 2018-03-22
EP3264921A1 (en) 2018-01-10
CN107846957A (zh) 2018-03-27
FI3264922T3 (fi) 2024-12-27
PT3264922T (pt) 2025-01-07
PH12017550041A1 (en) 2018-01-15
PH12017550039B1 (en) 2022-07-20
AU2016227597B2 (en) 2020-01-16
WO2016139330A1 (en) 2016-09-09
EP4494482A3 (en) 2025-04-23
MX2017010923A (es) 2018-01-16
PH12017550041B1 (en) 2022-08-05
US20210177872A1 (en) 2021-06-17
RU2731067C2 (ru) 2020-08-28
EP4508990A2 (en) 2025-02-19

Similar Documents

Publication Publication Date Title
MX2017011007A (es) Composicion para uso para mejorar la consistencia o la frecuencia de las heces en infantes o niños pequeños.
PH12017550040A1 (en) Compositions for use in the prevention or treatment of gastrointestinal infections/inflammations in infants or young children
MX380540B (es) Composiciones para uso en la prevención o el tratamiento de otitis o bronquitis en infantes o niños pequeños.
PH12018501325A1 (en) Compositions comprising human milk oligosaccharides for use in infants or young children to prevent or treat a health disorder by increasing glp-1 secretion
MX382069B (es) Composiciones que comprenden 2fl y lnnt para controlar la ingesta de alimento y el crecimiento en infantes o niños pequeños.
PH12016500773A1 (en) Compositions for use in the prevention or treatment of necrotizing enterocolitis in infants or young children born by c-section
PH12018501328A1 (en) Compositions comprising 2fl and lnnt for use in infants or young children to prevent later in life obesity or related comorbidities
PH12018501262A1 (en) Compositions comprising human milk oligosaccharides for use in infants or young children to prevent or treat allergies
PH12020550959A1 (en) Compositions for use in the reduction of nociception in infants and young children
MX377225B (es) Mezcla sintetica de oligosacaridos de la leche humana (hmo) y composición que la contiene.
PH12020550465A1 (en) Compositions comprising at least one n-acetylated and at least one fucosylated oligosaccharide for use in the promotion of digestive capacity in infants and young children
BR112015006605A2 (pt) vacina atenuada viva, método de produzir um arterivírus, arterivírus, e, complexo plp2-ubiquitina ou complexo plp2-isg15
PH12015502543B1 (en) Anti-regurgitation composition maintaining gut motility
PH12019500092A1 (en) Nutritional compositions for infants and/or young children comprising oligosaccharides
BR112017007362A2 (pt) composições nutricionais compreendendo sn-1(3)-monoacilgliceróis para uso no tratamento de atrasos de crescimento em bebês ou crianças
TH2001005750A (th) องค์ประกอบทางโภชนาการสำหรับใช้ในการป้องกันผิวแห้ง
NZ753208A (en) Anti-regurgitation composition maintaining gut motility
TWD178795S (zh) 嬰幼兒用椅子之部分
CN302493445S (zh) 婴童餐椅